All Resources
Our resource hub to discover reports, policy papers and other forms of informative content
Letter to The Honourable Jean-Yves Duclos, P.C., M.P.
IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process.
Letter to The Hon. Chrystia Freeland, P.C., M.P.
IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process.
*Cette lettre est disponible en anglais seulement.
Letter to The Honourable Mary Ng, P.C., M.P.
IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process.
*Cette lettre est disponible en anglais seulement.
Ministerial PMPRB Guideline Letter to The Hon. François-Philippe Champagne, P.C., M.P.
IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process.
Developing a Pan-Canadian Genomics Strategy: Innovative Medicines Canada Response
IMC supports the creation of a Pan Canadian Genomics Strategy (PCGS) to help Canada advance its international leadership and increase capacity in genomics through commercialization and adoption.
Letter to the Honourable Patty Hajdu
IMC requests that the Honourable Patty Hadju suspend the July 1, 2021 implementation of regulatory changes to the PMPRB until the COVID-19 pandemic has abated.
Standing Committee on International Trade (CIIT) study of Canada’s International Trade and Investment Policy
IMC appears before the CIIT to support its study of Canada’s trade agreements and trade and investment policies regarding how they may help or hinder the production and distribution of COVID-19 vaccines domestically and abroad.
IMC and BTC joint response to CADTH’s transparency consultation
IMC and and BIOTECanada write to Suzanne McGurn with joint input on the current CADTH process consultation.
Importation of Prescription Drugs; Proposed Rule
IMC comments on the notice of proposed rulemaking titled “Importation of Prescription Drugs” published by the U.S. Food and Drug Administration in the Federal Register, December 23, 2019.
